These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6234615

  • 1. [Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization].
    Moldenhauer H, Rose H, Saul G, Wolf G, Kehrberg G.
    Radiobiol Radiother (Berl); 1984; 25(2):289-95. PubMed ID: 6234615
    [No Abstract] [Full Text] [Related]

  • 2. Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
    Clement JJ, Gorman MS, Wodinsky I, Catane R, Johnson RK.
    Cancer Res; 1980 Nov; 40(11):4165-72. PubMed ID: 7471058
    [Abstract] [Full Text] [Related]

  • 3. Sensitization of cancer chemotherapeutic agents by nitroheterocyclics.
    Siemann DW, Mulcahy RT.
    Biochem Pharmacol; 1986 Jan 01; 35(1):111-5. PubMed ID: 3940521
    [No Abstract] [Full Text] [Related]

  • 4. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD, Millar JL, McElwain TJ.
    Am J Clin Oncol; 1982 Feb 01; 5(1):73-8. PubMed ID: 7081141
    [Abstract] [Full Text] [Related]

  • 5. Update: the potential for chemosensitization of alkylating agents by nitroimidazoles.
    Mulcahy RT.
    Oncology (Williston Park); 1988 Dec 01; 2(12):17-24, 27, 30-1 passim. PubMed ID: 3079289
    [Abstract] [Full Text] [Related]

  • 6. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
    White RA, Workman P, Brown JM.
    Radiat Res; 1980 Dec 01; 84(3):542-61. PubMed ID: 6450431
    [No Abstract] [Full Text] [Related]

  • 7. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P, Workman P.
    Br J Cancer; 1982 Mar 01; 45(3):447-55. PubMed ID: 7073938
    [Abstract] [Full Text] [Related]

  • 8. Timed-released depot for anticancer agents. II.
    Yolles S, Aslund B, Morton JF, Olson OT, Rosenberg B.
    Acta Pharm Suec; 1978 Mar 01; 15(5):382-8. PubMed ID: 747096
    [No Abstract] [Full Text] [Related]

  • 9. Modification of chemotherapy by nitroimidazoles.
    Siemann DW.
    Int J Radiat Oncol Biol Phys; 1984 Sep 01; 10(9):1585-94. PubMed ID: 6384159
    [Abstract] [Full Text] [Related]

  • 10. [Radioprotective phenomena in murine tumors induced by radiosensitizers at high dose levels].
    Shibamoto Y, Ono K, Takahashi M, Abe M, Hori H, Shibata T, Inayana S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1986 May 25; 46(5):725-7. PubMed ID: 3763390
    [No Abstract] [Full Text] [Related]

  • 11. Modification of alkylating agent cytotoxicity by cisplatin.
    Horsman MR, Hirst DG, Brown DM, Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Sep 25; 10(9):1669-73. PubMed ID: 6541216
    [Abstract] [Full Text] [Related]

  • 12. Modification of alkylating agent induced cell kill by 2-nitroimidazoles in unclamped and clamped SC 9L tumors.
    Wallen CA, Moore SK, Wheeler KT.
    Int J Radiat Oncol Biol Phys; 1992 Sep 25; 22(4):727-30. PubMed ID: 1531976
    [Abstract] [Full Text] [Related]

  • 13. Interactions of hyperthermia and chemotherapy in animals.
    Marmor JB.
    Cancer Res; 1979 Jun 25; 39(6 Pt 2):2269-76. PubMed ID: 87264
    [No Abstract] [Full Text] [Related]

  • 14. Clinical perspectives for the use of new hypoxic cell sensitizers.
    Brown JM.
    Int J Radiat Oncol Biol Phys; 1982 Sep 25; 8(9):1491-7. PubMed ID: 6216229
    [No Abstract] [Full Text] [Related]

  • 15. Effect of five antineoplastic agents on tumor xenografts with different growth rates.
    Mattern J, Wayss K, Volm M.
    J Natl Cancer Inst; 1984 Jun 25; 72(6):1335-9. PubMed ID: 6587154
    [Abstract] [Full Text] [Related]

  • 16. The effect of timing on chemosensitization by clinical levels of SR-2508.
    Hirst DG, Horsman MR, Brown JM, Hazlehurst JL.
    Int J Radiat Oncol Biol Phys; 1984 Sep 25; 10(9):1641-5. PubMed ID: 6237082
    [Abstract] [Full Text] [Related]

  • 17. Experimental cancer chemotherapy: strategy for cure.
    Cain BF.
    N Z Med J; 1971 Feb 25; 73(465):85-90. PubMed ID: 4994879
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of diethyl maleate (DEM) on the radiosensitization by misonidazole (MISO) in experimental animal tumors].
    Ono K, Takahashi M, Nishidai T, Dodo Y, Abe M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Mar 25; 44(3):517-22. PubMed ID: 6462898
    [No Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
    Pearlman NW, Meyers TJ, Siebert PE, Wallner SF, Carson SD, Campbell DN, Johnson FB, Kennaugh R, Rempel P.
    Cancer Treat Rep; 1983 Apr 25; 67(4):375-6. PubMed ID: 6303587
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.